---
title: "FAULKNER ERIC — Ownership Dossier"
canonical: https://whiteintel.dev/entity/67836274-e4d7-5b92-acf7-7650291fa028
json: https://whiteintel.dev/api/public/dossier/67836274-e4d7-5b92-acf7-7650291fa028
identifier: sec:0002113815
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# FAULKNER ERIC

**Type:** Company  
**Jurisdiction:** US  
**Identifier:** `sec:0002113815`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/67836274-e4d7-5b92-acf7-7650291fa028  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/67836274-e4d7-5b92-acf7-7650291fa028  

## Ownership & control

### Holdings / subsidiaries

- **CNS PHARMACEUTICALS, INC.** (officer) — https://whiteintel.dev/entity/a810e0a7-7c29-5686-bcee-bbe3b9b63680

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **FAULKNER ERIC**. Human view: https://whiteintel.dev/entity/67836274-e4d7-5b92-acf7-7650291fa028 · Structured JSON: https://whiteintel.dev/api/public/dossier/67836274-e4d7-5b92-acf7-7650291fa028._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._